6-160585045-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBA1

The NM_005577.4(LPA):​c.4289+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0361 in 1,613,234 control chromosomes in the GnomAD database, including 1,290 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 111 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1179 hom. )

Consequence

LPA
NM_005577.4 splice_donor, intron

Scores

2
5
Splicing: ADA: 1.000
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:2

Conservation

PhyloP100: 3.51

Publications

52 publications found
Variant links:
Genes affected
LPA (HGNC:6667): (lipoprotein(a)) The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
BP6
Variant 6-160585045-C-T is Benign according to our data. Variant chr6-160585045-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 403043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0551 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LPANM_005577.4 linkc.4289+1G>A splice_donor_variant, intron_variant Intron 26 of 38 ENST00000316300.10 NP_005568.2 P08519

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LPAENST00000316300.10 linkc.4289+1G>A splice_donor_variant, intron_variant Intron 26 of 38 1 NM_005577.4 ENSP00000321334.6 P08519

Frequencies

GnomAD3 genomes
AF:
0.0301
AC:
4571
AN:
152072
Hom.:
112
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00746
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0584
Gnomad ASJ
AF:
0.0239
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0369
Gnomad FIN
AF:
0.0529
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0364
Gnomad OTH
AF:
0.0253
GnomAD2 exomes
AF:
0.0405
AC:
10118
AN:
249794
AF XY:
0.0388
show subpopulations
Gnomad AFR exome
AF:
0.00709
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.0269
Gnomad EAS exome
AF:
0.000990
Gnomad FIN exome
AF:
0.0468
Gnomad NFE exome
AF:
0.0339
Gnomad OTH exome
AF:
0.0370
GnomAD4 exome
AF:
0.0367
AC:
53600
AN:
1461044
Hom.:
1179
Cov.:
32
AF XY:
0.0363
AC XY:
26406
AN XY:
726870
show subpopulations
African (AFR)
AF:
0.00583
AC:
195
AN:
33436
American (AMR)
AF:
0.0978
AC:
4374
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0260
AC:
680
AN:
26112
East Asian (EAS)
AF:
0.000580
AC:
23
AN:
39682
South Asian (SAS)
AF:
0.0339
AC:
2925
AN:
86246
European-Finnish (FIN)
AF:
0.0478
AC:
2552
AN:
53414
Middle Eastern (MID)
AF:
0.0296
AC:
170
AN:
5750
European-Non Finnish (NFE)
AF:
0.0365
AC:
40576
AN:
1111352
Other (OTH)
AF:
0.0349
AC:
2105
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2454
4908
7363
9817
12271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1602
3204
4806
6408
8010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0300
AC:
4572
AN:
152190
Hom.:
111
Cov.:
32
AF XY:
0.0313
AC XY:
2331
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00744
AC:
309
AN:
41550
American (AMR)
AF:
0.0582
AC:
889
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0239
AC:
83
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.0371
AC:
179
AN:
4822
European-Finnish (FIN)
AF:
0.0529
AC:
559
AN:
10576
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0365
AC:
2480
AN:
68008
Other (OTH)
AF:
0.0250
AC:
53
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
234
469
703
938
1172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0318
Hom.:
362
Bravo
AF:
0.0304
TwinsUK
AF:
0.0332
AC:
123
ALSPAC
AF:
0.0371
AC:
143
ESP6500AA
AF:
0.00732
AC:
31
ESP6500EA
AF:
0.0346
AC:
295
ExAC
AF:
0.0369
AC:
4478
Asia WGS
AF:
0.0200
AC:
71
AN:
3478
EpiCase
AF:
0.0335
EpiControl
AF:
0.0344

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Lipoprotein(a) deficiency, congenital Pathogenic:1
Aug 07, 2020
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

LPA-related disorder Benign:1
Mar 10, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
24
DANN
Benign
0.93
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Benign
0.75
D
PhyloP100
3.5
GERP RS
2.6
Mutation Taster
=29/71
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.77
SpliceAI score (max)
0.52
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.52
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41272114; hg19: chr6-161006077; COSMIC: COSV108142826; COSMIC: COSV108142826; API